Oncternal Therapeutics oncternal.com


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Oncternal Therapeutics is a clinical-stage oncology company developing therapies for both rare and common cancers by focusing on targets that are uniquely expressed within cancer cells. The company is advancing its two pipeline products, cirmtuzumab, an-anti ROR1 monoclonal antibody, and TK216, a small molecule that inhibits the biological activity of ets-family transcription factor oncoproteins.

Oncternal Therapeutics is a clinical-stage oncology company developing therapies for both rare and common cancers by focusing on targets that are uniquely expressed within cancer cells. The company is advancing its two pipeline products, cirmtuzumab,...Show all

Company (IPO / Went public)

Phone: 858-434-1113

Fax:

3525 Del Mar Heights Road
#821
San Diego, 92130
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oncternal Therapeutics $56.8M Mar 7, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oncternal Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Indolinone compounds and uses thereof Nov 21, 2016 Feb 20, 2018 Patent
Indoline analogs and uses thereof Mar 16, 2017 Nov 21, 2017 Patent
Indolinone compounds and uses thereof Oct 07, 2015 Mar 28, 2017 Patent
Indoline analogs and uses thereof Aug 18, 2017 Application
Uses of indolinone compounds Jul 26, 2017 Application